OLVCX
Price
$19.42
Change
+$0.14 (+0.73%)
Updated
Jun 26 closing price
Net Assets
5.02B
RMFEX
Price
$58.62
Change
+$0.43 (+0.74%)
Updated
Jun 26 closing price
Net Assets
106.24B
Interact to see
Advertisement

OLVCX vs RMFEX

Header iconOLVCX vs RMFEX Comparison
Open Charts OLVCX vs RMFEXBanner chart's image
JPMorgan Large Cap Value C
Price$19.42
Change+$0.14 (+0.73%)
VolumeN/A
Net Assets5.02B
American Funds American Mutual R4
Price$58.62
Change+$0.43 (+0.74%)
VolumeN/A
Net Assets106.24B
OLVCX vs RMFEX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
OLVCX vs. RMFEX commentary
Jun 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is OLVCX is a Buy and RMFEX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RMFEX has more cash in the bank: 106B vs. OLVCX (5.02B). RMFEX pays higher dividends than OLVCX: RMFEX (1.58) vs OLVCX (0.57). OLVCX was incepted earlier than RMFEX: OLVCX (26 years) vs RMFEX (23 years). OLVCX (1.50) is less costly to investors than RMFEX (0.62). OLVCX is a more actively managed with annual turnover of: 167.00 vs. RMFEX (31.00). RMFEX has a lower initial minimum investment than OLVCX: RMFEX (250) vs OLVCX (1000). RMFEX annual gain was more profitable for investors over the last year : 9.98 vs. OLVCX (1.03). OLVCX (67.10) and RMFEX (66.41) have equivalent 5 years return.
OLVCXRMFEXOLVCX / RMFEX
Total Expense Ratio1.440.62232%
Annual Report Gross Expense Ratio1.500.62242%
Fund Existence26 years23 years-
Gain YTD1.8927.54625%
Front LoadN/AN/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets5.02B106B5%
Annual Yield % from dividends0.571.5836%
Returns for 1 year1.039.9810%
Returns for 3 years12.8927.5847%
Returns for 5 years67.1066.41101%
Returns for 10 years39.9182.9748%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ADNT19.710.36
+1.86%
Adient plc
CLS150.151.11
+0.74%
Celestica
REPL9.460.01
+0.11%
Replimune Group
NVCT7.71-0.03
-0.39%
Nuvectis Pharma
IBIO0.71-0.02
-2.74%
iBio